- Home
- MMU vs PRME Comparison
MMU vs PRME Comparison
Compare MMU & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMU
- PRME
- Stock Information
- Founded
- MMU 1992
- PRME 2019
- Country
- MMU United States
- PRME United States
- Employees
- MMU N/A
- PRME N/A
- Industry
- MMU Investment Managers
- PRME Medicinal Chemicals and Botanical Products
- Sector
- MMU Finance
- PRME Health Care
- Exchange
- MMU Nasdaq
- PRME Nasdaq
- Market Cap
- MMU 547.8M
- PRME 624.0M
- IPO Year
- MMU N/A
- PRME 2022
- Fundamental
- Price
- MMU $9.87
- PRME $3.55
- Analyst Decision
- MMU
- PRME Buy
- Analyst Count
- MMU 0
- PRME 6
- Target Price
- MMU N/A
- PRME $8.88
- AVG Volume (30 Days)
- MMU 170.7K
- PRME 4.0M
- Earning Date
- MMU 01-01-0001
- PRME 08-07-2025
- Dividend Yield
- MMU 4.92%
- PRME N/A
- EPS Growth
- MMU N/A
- PRME N/A
- EPS
- MMU N/A
- PRME N/A
- Revenue
- MMU N/A
- PRME $4,961,000.00
- Revenue This Year
- MMU N/A
- PRME $126.92
- Revenue Next Year
- MMU N/A
- PRME $87.32
- P/E Ratio
- MMU N/A
- PRME N/A
- Revenue Growth
- MMU N/A
- PRME 739.42
- 52 Week Low
- MMU $8.60
- PRME $1.11
- 52 Week High
- MMU $10.45
- PRME $5.17
- Technical
- Relative Strength Index (RSI)
- MMU 43.95
- PRME 48.57
- Support Level
- MMU $9.85
- PRME $3.09
- Resistance Level
- MMU $9.99
- PRME $3.88
- Average True Range (ATR)
- MMU 0.08
- PRME 0.31
- MACD
- MMU -0.01
- PRME -0.09
- Stochastic Oscillator
- MMU 32.50
- PRME 32.96
About MMU Western Asset Managed Municipals Fund Inc.
Western Asset Managed Municipals Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is to maximize current income exempted from federal income tax as is consistent with the preservation of principal. It predominantly invests in long-term investment grade municipal debt securities issued by state and local governments, political subdivisions, agencies, and public authorities (municipal obligations). Under normal market conditions, a majority of its total assets are invested in municipal obligations rated investment grade at the time of investment.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.